Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

Publication date: Available online 31 August 2017
Source:American Journal of Infection Control
Author(s): Stephen P. Blatt, Aleksandr Yultyev, Miao Huang, Scott Friedstrom, Jennifer Steinbrunner
We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.



http://ift.tt/2gw04cX